ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• eISF In European Clinical Trials And How eBinders Can Help

  By addressing the unique hurdles tied to regulations in European clinical trials, eBinders offer a streamlined approach to managing electronic trial documentation.

• Regulatory Guidance For PRO Strategy In Oncology Trials

  Kelly Dumais, Principal Scientific Advisor, and Jowita Marszewska, Scientific Advisor at Clario eCOA, delve into the specifics of how recent regulatory advancements are influencing PRO Strategy.

• Do We Still Need Patients In Tomorrow's Trials?

  Delve into how advanced technologies reshape drug development and patient care, and the crucial balance needed between innovation and ethical responsibility to achieve better trial outcomes.

• One Day, Clinical Trials Will Represent The Real World

  What needs to happen for RWE to reach its full regulatory potential? We discussed this with industry leaders during the One Day Summit, and here are some key takeaways.

• How To Migrate Active Studies To A New EDC

  Gain access to the results and lessons learned from a project involving the modernization of an electronic data capture system and mid-study data migrations.

• Combining Patient-Centric Technology and RWD For Comprehensive Evidence

  Explore how by combining digital technologies with secondary RWD, researchers can gather a more holistic understanding of the patient. 

• Increase Participant Diversity With eClinical Tools

  The right technology and community partnerships can help sponsors meet FDA diversity requirements without additional expenditures, build relationships with minorities, and prepare for future trials.

• Reliable Methods For Examining Long-Term Wearables In Gait & Sway

  Review this evaluation framework for wear duration when confirming if wearable sensor-based methods for capturing gait and balance impairment in the free-living environment are fit for purpose.

• Accelerating Clinical Data Review With Traceable Workflows

  Clinical data review needs centralized access and traceable workflows. Leveraging AI-automation and real-time collaboration drives faster, better-informed decisions and reduced compliance risk.

• Can Your Clinical Trial Design Handle Mid-Study Changes?

  Mid-study changes are frequently inevitable, but it’s possible to reduce the downtime they create with strategic planning and technology. See how to plan for mid-study changes that mitigate downtime.